This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Prescribing Information for NGENLA▼(somatrogon) can be found here. Prescribing Information for Genotropin (somatropin) can be found here. Adverse event reporting information can be found at the bottom of the page.
The Ngenla device is designed for patients' ease of use and convenience1, 2,3
Once primed, NGENLA can be administered in 3 steps:
Watch National Endocrine Clinical Training Lead Claire Snow demonstrate how to use the Ngenla pen.
This video demonstrates the 24mg pen. For the 60mg pen the steps are the same - the only difference is during priming, where after two clicks, 1.0mg will be displayed in the window, as opposed to 0.4mg.
For instructions on how to use the NGENLA pen see the PIL for Northern Ireland and
PIL for Great Britain.
Access PIP Codes and key details on how to order NGENLA for your patients.
Access practical support for initiating patients on NGENLA and learn more about how NGENLA may deliver a treatment experience favoured by patients and caregivers.1
References:
Find out information about the starter kits available to patients starting treatment with NGENLA.
Download the document to access information supporting fomulary application for NGENLA.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024